                               SEQUENCE LISTING

<110> THE REGENTS OF THE UNIVERSITY OF CALIFORNIA
 
<120> IMMUNOMODULATORY COMPOUNDS

<130> 24978-0571

<140> PCT/US2020/045568
<141> 2020-08-10

<150> 62/884,699
<151> 2019-08-09

<160> 9     

<170> PatentIn version 3.5

<210> 1
<211> 119
<212> PRT
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      polypeptide

<400> 1
Gln Val Gln Leu Gln Gln Ser Gly Ala Glu Leu Val Arg Pro Gly Thr 
1               5                   10                  15      


Ser Val Lys Leu Ser Cys Lys Val Ser Gly Asp Thr Ile Thr Ala Tyr 
            20                  25                  30          


Tyr Ile His Phe Val Lys Gln Arg Pro Gly Gln Gly Leu Glu Trp Ile 
        35                  40                  45              


Gly Arg Ile Asp Pro Glu Asp Asp Ser Thr Glu Tyr Ala Glu Lys Phe 
    50                  55                  60                  


Lys Asn Lys Ala Thr Ile Thr Ala Asn Thr Ser Ser Asn Thr Ala His 
65                  70                  75                  80  


Leu Lys Tyr Ser Arg Leu Thr Ser Glu Asp Thr Ala Thr Tyr Phe Cys 
                85                  90                  95      


Thr Thr Asp Asn Met Gly Ala Thr Glu Phe Val Tyr Trp Gly Gln Gly 
            100                 105                 110         


Thr Leu Val Thr Val Ser Ser 
        115                 


<210> 2
<211> 113
<212> PRT
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      polypeptide

<400> 2
Gln Val Val Leu Thr Gln Pro Lys Ser Val Ser Ala Ser Leu Glu Ser 
1               5                   10                  15      


Thr Val Lys Leu Ser Cys Lys Leu Asn Ser Gly Asn Ile Gly Ser Tyr 
            20                  25                  30          


Tyr Met His Trp Tyr Gln Gln Arg Glu Gly Arg Ser Pro Thr Asn Leu 
        35                  40                  45              


Ile Tyr Arg Asp Asp Lys Arg Pro Asp Gly Ala Pro Asp Arg Phe Ser 
    50                  55                  60                  


Gly Ser Ile Asp Ile Ser Ser Asn Ser Ala Phe Leu Thr Ile Asn Asn 
65                  70                  75                  80  


Val Gln Thr Glu Asp Glu Ala Met Tyr Phe Cys His Ser Tyr Asp Gly 
                85                  90                  95      


Arg Met Tyr Ile Phe Gly Gly Gly Thr Lys Leu Thr Val Leu Gly Gln 
            100                 105                 110         


Pro 
    


<210> 3
<211> 5
<212> PRT
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      peptide

<400> 3
Ala Tyr Tyr Ile His 
1               5   


<210> 4
<211> 16
<212> PRT
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      peptide

<400> 4
Arg Ile Asp Pro Glu Asp Asp Ser Thr Glu Tyr Ala Glu Lys Phe Lys 
1               5                   10                  15      


<210> 5
<211> 8
<212> PRT
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      peptide

<400> 5
Phe Cys Thr Thr Asp Asn Met Gly 
1               5               


<210> 6
<211> 11
<212> PRT
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      peptide

<400> 6
Leu Asn Ser Gly Asn Ile Gly Ser Tyr Tyr Met 
1               5                   10      


<210> 7
<211> 7
<212> PRT
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      peptide

<400> 7
Tyr Arg Asp Asp Lys Arg Pro 
1               5           


<210> 8
<211> 9
<212> PRT
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      peptide

<400> 8
Tyr Phe Cys His Ser Tyr Asp Gly Arg 
1               5                   


<210> 9
<211> 20
<212> PRT
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      peptide

<400> 9
Gly Gly Gly Gly Ser Gly Gly Gly Gly Ser Gly Gly Gly Gly Ser Gly 
1               5                   10                  15      


Gly Gly Gly Ser 
            20  


